BioPharma Diagnostics offers access to the infectious disease testing capabilities of Mayo Clinic’s internationally renowned clinical microbiology laboratories. With more than 70 years of testing experience, our laboratories span all areas of conventional and molecular medical microbiology, offering a broad selection of tests designed for rapid identification and in-depth characterization of the bacterial, viral, fungal, and parasitic agents of infectious diseases.

Performing more than four million tests annually, our seven clinical microbiology laboratories have developed and implemented in vitro and culture techniques, immunoassays, antimicrobial susceptibility testing, and molecular methods for rapid detection, identification, and characterization of microbial pathogens.

Our laboratories are managed by physician-scientists, many of whom are actively engaged in clinical practice and research. Through BioPharma Diagnostics, our partners have access to a wealth of world-renowned expertise to help guide test ordering and interpret results.

Test menu

Comprehensive disease testing

Through BioPharma Diagnostics, our partners have access to Mayo Clinic Laboratories’ infectious disease test catalog, including testing for:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  • Helicobacter pylori
  • Infectious disease pathology
  • Vector-borne diseases
  • HIV and hepatitis

Our molecular testing methods include:

  • Polymerase chain reaction (PCR) testing
  • Advanced whole genome microbial sequencing
  • Targeted metagenomic sequencing
  • Matrix-assisted laser-desorption/ionization-time of flight (MALDI-TOF) mass spectrometry organism identification

In addition to using clinically available testing, BioPharma Diagnostics partners can access infectious disease testing for clinical trials and be among the first to use up-and-coming tests currently in development.

News and updates

The latest

View More

Fill out the form below and one of our specialists will be in touch.